bioAffinity Technologies, Inc. Common Stock (BIAF) is a publicly traded Healthcare sector company. As of September 17, 2026, BIAF trades at $6.69 with a market cap of $3.82M and a P/E ratio of -0.81. BIAF moved +28.97% today. Year to date, BIAF is -69.77%; over the trailing twelve months it is -95.44%. Its 52-week range spans $4.56 to $697.95. Rallies surfaces BIAF's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
BIAF financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. BIAF recently traded at $6.69. Market cap is $3.82M. P/E ratio is -0.81. Revenue is $5.90M.
| Metric | Value |
|---|---|
| Price | $6.69 |
| Market Cap | $3.82M |
| P/E Ratio |
| -0.81 |
| EPS | $-7.30 |
|---|
| Dividend Yield | 0.00% |
|---|
| 52-Week High | $697.95 |
|---|
| 52-Week Low | $4.56 |
|---|
| Volume | 8.66M |
|---|
| Avg Volume | 0 |
|---|
| Revenue (TTM) | $5.90M |
|---|
| Net Income | $-15.19M |
|---|
| Gross Margin | 0.00% |
|---|
BIAF analyst coverage data. Average price target: $0.00.